Changes in bioimpedance by sex. by Domingos L. S. Rios (20496173)

“…In men, BMI and fat mass decreased by 12.9% and 25.3 at 3 months and 23.6% and 45.3% at 6 months, respectively. …”

Changes in bioimpedance by age. by Domingos L. S. Rios (20496173)

“…In men, BMI and fat mass decreased by 12.9% and 25.3 at 3 months and 23.6% and 45.3% at 6 months, respectively. …”

S1 Data - by Domingos L. S. Rios (20496173)

“…In men, BMI and fat mass decreased by 12.9% and 25.3 at 3 months and 23.6% and 45.3% at 6 months, respectively. …”

Minimal raw clinical data with anonymization. by Seung-Jae Joo (3620240)

Intensity of 7-day running training in rats. by Chengcheng Li (2591632)

“…<div><p> Background </p><p>Rhabdomyolysis (RM), particularly heat exhaustion-associated rhabdomyolysis (ehsRM), is a significant clinical issue associated with high mortality and healthcare costs. …”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”

Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

“…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”

Baseline Characteristics of Study Participants. by Swati M. Surkar (8399427)

Raw and processed data files. by Swati M. Surkar (8399427)

Transcriptional analysis of <i>L. infantum</i>-infected macrophages from female and male donors 16 hpi. by Annika Bea (17686341)

Transcriptional analysis of <i>L. infantum</i>-infected macrophages from female and male donors 6 hpi. by Annika Bea (17686341)

Transcriptional analysis of <i>L. infantum</i>-infected macrophages from female and male donors. by Annika Bea (17686341)

Study design. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Antimicrobial Treatments. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Routine sporotrichosis laboratory tests. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

Patient characteristics. by Helena Duani (22522200)

“…Notably, with each additional year of age, the chances of rapid healing decreased by 2%.</p><p>Conclusion</p><p>Our findings suggest that adjuvant hyperbaric oxygen therapy significantly accelerates the healing of fixed cutaneous/lymphocutaneous sporotrichosis. …”

MRI grading systems’ diagnostic accuracy for MD. by Neda Azarpey (20308334)

“…<div><p>Background</p><p>The diagnosis of Meniere’s Disease (MD) presents significant challenges due to its complex symptomatology and the absence of definitive biomarkers. …”

MRI-based cochlear hydrops grading and PLE in MD. by Neda Azarpey (20308334)

“…<div><p>Background</p><p>The diagnosis of Meniere’s Disease (MD) presents significant challenges due to its complex symptomatology and the absence of definitive biomarkers. …”

Cochlear hydrops classification in MRI systems. by Neda Azarpey (20308334)

“…<div><p>Background</p><p>The diagnosis of Meniere’s Disease (MD) presents significant challenges due to its complex symptomatology and the absence of definitive biomarkers. …”